Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: May 8, 2024
Abstract
Systematical
and
critical
learning
from
industrial
catalysis
will
bring
inspiration
for
emerging
nanocatalytic
medicine,
but
the
relevant
knowledge
is
quite
limited
so
far.
In
this
review,
we
briefly
summarize
representative
catalytic
reactions
corresponding
catalysts
in
industry,
then
distinguish
similarities
differences
between
medical
applications
support
of
learning,
deep
understanding,
rational
designing
appropriate
various
applications.
Finally,
summarize/outlook
present
potential
translation
to
medicine.
This
review
expected
display
a
clear
picture
medicine
evolution.
ACS Nano,
Journal Year:
2023,
Volume and Issue:
17(3), P. 2943 - 2957
Published: Jan. 23, 2023
The
microenvironments
with
high
reactive-oxygen-species
(ROS)
levels,
inflammatory
responses,
and
oxidative-stress
effects
in
diabetic
ulcer
wounds,
leading
to
poor
proliferation
differentiation
of
stem
cells,
severely
inhibit
their
efficient
healing.
Here,
overcome
the
unbalanced
multielectron
reactions
ROS
catalysis,
we
develop
a
cobalt
selenide-based
biocatalyst
an
amorphous
Ru@CoSe
nanolayer
for
ultrafast
broad-spectrum
catalytic
ROS-elimination.
Owing
enriched
electrons
more
unoccupied
orbitals
Ru
atoms,
nanolayer-equipped
displays
excellent
catalase-like
kinetics
(maximal
reaction
velocity,
23.05
μM
s–1;
turnover
number,
2.00
s–1),
which
exceeds
most
currently
reported
metal
compounds.
theoretical
studies
show
that
atoms
act
as
"regulators"
tune
electronic
state
Co
sites
modulate
interaction
oxygen
intermediates,
thus
improving
reversible
redox
properties
active
sites.
Consequently,
can
efficiently
rescue
mesenchymal
cells
maintain
angiogenic
potential
oxidative
stress
environment.
In
vivo
experiments
reveal
superior
ROS-elimination
ability
on
wound.
This
study
offers
effective
nanomedicine
ROS-scavenging
healing
wounds
also
provides
strategy
design
biocatalytic
compounds
via
bringing
structures.
Advanced Materials,
Journal Year:
2023,
Volume and Issue:
36(10)
Published: April 5, 2023
Metabolism
is
the
sum
of
enzyme-dependent
chemical
reactions,
which
produces
energy
in
catabolic
process
and
synthesizes
biomass
anabolic
process,
exhibiting
high
similarity
mammalian
cell,
microbial
plant
cell.
Consequently,
loss
or
gain
metabolic
enzyme
activity
greatly
affects
cellular
metabolism.
Nanozymes,
as
emerging
mimics
with
diverse
functions
adjustable
catalytic
activities,
have
shown
attractive
potential
for
regulation.
Although
basic
tasks
are
highly
similar
cells
from
different
species,
concrete
pathway
varies
intracellular
structure
species.
Here,
metabolism
living
organisms
described
similarities
differences
pathways
among
mammalian,
microbial,
regulation
mechanism
discussed.
The
recent
progress
on
mainly
including
nutrient
uptake
utilization,
production,
accompanied
redox
reactions
by
kinds
oxidoreductases
their
applications
field
disease
therapy,
antimicrobial
sustainable
agriculture
systematically
reviewed.
Furthermore,
prospects
challenges
nanozymes
regulating
cell
also
discussed,
broaden
application
scenarios.
Advanced Materials,
Journal Year:
2023,
Volume and Issue:
35(44)
Published: Aug. 23, 2023
Inflammatory
bowel
disease
(IBD)
affects
millions
of
individuals
worldwide
annually.
Enteric
reactive
oxygen
species
(ROS)
play
critical
roles
in
the
physiology
and
pathology
IBD.
Nanozymes
hold
great
promise
for
treatment
IBD
because
their
exceptional
ability
to
regulate
redox
homeostasis
during
ROS-related
inflammation.
However,
rapid
development
orally
administered,
acid-tolerant,
antioxidant
nanozymes
therapy
is
challenging.
Here,
a
nine-tier
high-throughput
screening
strategy
established
address
multifaceted
demands,
including
intrinsic
stability,
radioactivity,
solubility,
gut
microbiome
toxicity,
biomimetic
elements,
intermediate
frontier
molecular
orbitals,
reaction
energy
barriers,
negative
charges,
acid
tolerance.
Ni3
S4
selected
as
best
matching
material
from
146
323
candidates,
which
exhibits
superoxide
dismutase-catalase
bienzyme-like
activity
3.13-
1.80-fold
more
active
than
natural
enzymes.
As
demonstrated
mouse
model,
stable
gastrointestinal
tract
without
toxicity
specifically
targets
diseased
colon
alleviate
oxidative
stress.
RNA
16S
rRNA
sequencing
analyses
show
that
effectively
inhibits
cellular
pathways
pro-inflammatory
factors
restores
microbiota.
This
study
not
develops
highly
efficient
administered
cascade
nanozyme
offers
next-generation
paradigm
rational
design
nanomedicine
through
data-driven
approaches.
Advanced Functional Materials,
Journal Year:
2023,
Volume and Issue:
33(49)
Published: July 28, 2023
Abstract
Abnormal
activation
of
the
gut
mucosal
immune
system
and
a
highly
dysregulated
microbiota
play
essential
roles
in
progression
inflammatory
bowel
disease
(IBD).
The
clinical
treatment
IBD
remains
challenging,
with
first‐line
drugs
showing
limited
efficacy
significant
side
effects.
A
reactive
oxygen
species
(ROS)‐activated
CO
versatile
nanomedicine
(CMPs)
capable
remodeling
immune‐microbiota
microenvironment
via
potent
anti‐oxidant,
anti‐inflammatory,
antimicrobial
effects
is
developed.
CORM‐401‐loaded
mannose‐modified
peptide
dendrimer
nanogel:
CMPs
preferentially
congregate
on
surface
damaged
colon
mucosa
after
rectal
administration
are
subsequently
internalized
by
activated
cells.
CORM‐401
can
release
numerous
molecules
response
to
high
ROS
levels
cells
at
site
IBD,
resulting
multiple
therapeutic
In
vitro
vivo
studies
have
demonstrated
that
scavenge
ROS,
suppress
responses,
eliminate
pathogens,
alleviate
colitis
mouse
models.
RNA
sequencing
reveals
successfully
remodel
homeostasis
scavenging
inhibiting
NF‐κB/p38MAPK,
activating
PI3K‐Akt,
HIF‐1‐induced
glycolysis.
16S
ribosomal
shows
flora
composition
restraining
detrimental
bacteria
augmenting
beneficial
bacteria.
This
study
develops
promising
for
management
IBD.
Chemical Society Reviews,
Journal Year:
2024,
Volume and Issue:
53(3), P. 1167 - 1315
Published: Jan. 1, 2024
Silicon-based
biomaterials
have
been
extensively
developed
in
the
past
decades.
The
classification,
characteristics,
multi-dimensional
design,
and
biomedical
applications
of
silicon-containing
are
comprehensively
elaborated.
Advanced Materials,
Journal Year:
2024,
Volume and Issue:
36(19)
Published: Feb. 7, 2024
Current
approaches
to
treating
inflammatory
bowel
disease
focus
on
the
suppression
of
overactive
immune
responses,
removal
reactive
intestinal
oxygen
species,
and
regulation
flora.
However,
owing
complex
structure
gastrointestinal
tract
influence
mucus,
current
small-molecule
biologic-based
drugs
for
colitis
cannot
effectively
act
at
site
colon
inflammation,
as
a
result,
they
tend
exhibit
low
efficacies
toxic
side
effects.
In
this
study,
nanogel-based
multistage
NO
delivery
microcapsules
are
developed
achieve
release
inflammation
by
targeting
tissues
using
nanogel.
Surprisingly,
oral
administration
suppresses
growth
pathogenic
bacteria
increases
abundance
probiotic
bacteria.
Metabolomics
further
show
that
an
increased
probiotics
promotes
production
metabolites,
including
short-chain
fatty
acids
indole
derivatives,
which
modulate
immunity
restore
barrier
via
interleukin-17
PI3K-Akt
signaling
pathways.
This
work
reveals
gas
therapy
strategy
based
modulates
microbial
balance,
thereby
reducing
promoting
repair,
ultimately
providing
new
therapeutic
approach
clinical
management
colitis.
Journal of Nanobiotechnology,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: Jan. 3, 2024
Abstract
There
is
a
growing
body
of
evidence
indicating
close
association
between
inflammatory
bowel
disease
(IBD)
and
disrupted
intestinal
homeostasis.
Excessive
production
reactive
oxygen
species
(ROS)
nitrogen
(RNS),
along
with
an
increase
in
M1
proinflammatory
macrophage
infiltration
during
the
activation
inflammation,
plays
pivotal
role
disrupting
homeostasis
IBD.
The
overabundance
ROS/RNS
can
cause
tissue
damage
disruption
crucial
gut
proteins,
which
ultimately
compromises
integrity
barrier.
proliferation
macrophages
contributes
to
exaggerated
immune
response,
further
compromising
Currently,
nanomaterials
have
gained
widespread
attention
context
IBD
due
their
notable
characteristics,
including
ability
specifically
target
regions
interest,
clear
excess
ROS/RNS,
mimic
biological
enzymes.
In
this
review,
we
initially
elucidated
microenvironment
Subsequently,
delineate
therapeutic
strategies
involving
two
distinct
types
nanomedicine,
namely
inorganic
nanoparticles
natural
product
nanomaterials.
Finally,
present
comprehensive
overview
promising
prospects
associated
application
nanomedicine
future
clinical
settings
for
treatment
(graphic
abstract).
Graphical
Bioactive Materials,
Journal Year:
2024,
Volume and Issue:
35, P. 167 - 180
Published: Jan. 28, 2024
Reactive
oxygen
species
(ROS),
immune
dysregulation-induced
inflammatory
outbreaks
and
microbial
imbalance
play
critical
roles
in
the
development
of
bowel
disease
(IBD).
Herein,
a
novel
enzyme-like
biomimetic
oral-agent
ZnPBA@YCW
has
been
developed,
using
yeast
cell
wall
(YCW)
as
outer
shell
zinc-doped
Prussian
blue
analogue
(ZnPBA)
nanozyme
inside.
When
orally
administered,
is
able
to
adhere
Phytomedicine,
Journal Year:
2024,
Volume and Issue:
129, P. 155564 - 155564
Published: March 23, 2024
The
incidence
of
ulcerative
colitis
(UC)
is
on
the
rise
globally
and
development
drugs
targeting
UC
urgent.
Finding
target
action
natural
products
important
for
drug
discovery,
elucidation
mechanism,
disease
mechanism.
San-Ye-Qing
(SYQ),
an
ancient
herbal
medicine,
but
whether
powder
its
rhizome
has
pharmacological
effects
against
mechanism
are
not
clear.